IMMUNOMEDICS, INC.
🏢 View company profile →412Patents
270Active
412Granted
54Portfolio score
Filing activity: Nov 7, 1983 → Jun 28, 2024 · 84 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6306393A | Immunotherapy of B-cell malignancies using anti-CD22 antibodies | Human Necessities | 388 | Expired |
| US5789554A | Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells | Chemistry; Metallurgy | 302 | Expired |
| US6187287A | Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells | Chemistry; Metallurgy | 234 | Expired |
| US6183744A | Immunotherapy of B-cell malignancies using anti-CD22 antibodies | Human Necessities | 216 | Expired |
| US7151164B2 | Anti-CD20 antibodies and fusion proteins thereof and methods of use | Chemistry; Metallurgy | 201 | Expired |
| US6653104B2 | Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells | Chemistry; Metallurgy | 194 | Expired |
| US4680338A | Bifunctional linker | Emerging Cross-Sectional Technologies | 192 | Expired |
| US5443953A | Preparation and use of immunoconjugates | Human Necessities | 180 | Expired |
| US5716595A | Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments | Human Necessities | 180 | Expired |
| US6096289A | Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy | Human Necessities | 174 | Expired |
| US6077499A | Targeted combination immunotherapy of cancer | Human Necessities | 173 | Expired |
| US7312318B2 | Internalizing anti-CD74 antibodies and methods of use | Chemistry; Metallurgy | 168 | Expired |
| US4735210A | Lymphographic and organ imaging method and kit | Human Necessities | 155 | Expired |
| US4925648A | Detection and treatment of infectious and inflammatory lesions | Emerging Cross-Sectional Technologies | 154 | Expired |
| US5332567A | Detection and treatment of infections with immunoconjugates | Human Necessities | 151 | Expired |
| US7074403B1 | Immunotherapy of autoimmune disorders using antibodies which target B-cells | Chemistry; Metallurgy | 138 | Expired |
| US7238785B2 | RS7 antibodies | Chemistry; Metallurgy | 132 | Expired |
| US4932412A | Intraoperative and endoscopic tumor detection and therapy | Human Necessities | 127 | Expired |
| US6254868A | Glycosylated humanized B-cell specific antibodies | Chemistry; Metallurgy | 126 | Expired |
| US5101827A | Lymphographic and organ imaging method and kit | Physics | 126 | Expired |
| US4699880A | Method of producing monoclonal anti-idiotype antibody | Emerging Cross-Sectional Technologies | 123 | Expired |
| US5697902A | Method for imaging and treating organs and tissues | Emerging Cross-Sectional Technologies | 121 | Expired |
| US5525338A | Detection and therapy of lesions with biotin/avidin conjugates | Human Necessities | 118 | Expired |
| US6387350B2 | Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy | Human Necessities | 117 | Expired |
| US4824659A | Antibody conjugates | Human Necessities | 116 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.